Press
Covance Licenses B-CLEAR®, A Proprietary Pharmacokinetic Product From Qualyst, Inc.
Qualyst announces support of 3rd Annual Hepatocyte Research Association Meeting.
Qualyst announces oversubscribed closing of its Series B Financing and the continued expansion of its client base.
Qualyst Announces Hepatic Drug Transport Seminar in San Francisco Bay Area.
Qualyst Announces Appointment of Yuichi Sugiyama to Scientific Advisory Board.
SC BioSciences and Qualyst announce alliance for commercialization of B-CLEAR® in Japan.
Qualyst Receives Notice of Patent Application Allowance in Europe for B-CLEAR®
Qualyst announces Predictive Liver Biliary Clearance Seminar in Cambridge, MA
Qualyst Announces Support of 2nd Annual Hepatocyte Research Association Meeting.
Qualyst, Inc. Selected to Present at CED’s Venture 2005, Awarded Biotechnology Center Funding.
Qualyst’s B-CLEAR® now available from MDS Drug Development Programs Group in North America.
Qualyst announces formation of Business Advisory Board that includes Pamela Kirby, former CEO of Quintiles Transnational Corporation.
Qualyst adds world renowned scientists to its newly created Scientific Advisory Board.
Qualyst announces award of Collaborative Funding Grant and the addition of Senior Director Business Development to support current and growing customer base.